Advertisement

Statistical Models for Predicting the Duration of Vaccine-Induced Protection

  • 9 Citations

Abstract

When new vaccine products are marketed, they are generally supported by clinical studies lasting only a few years. The duration of protection from disease, however, is often expected to be considerably longer than the time spans of the clinical studies. Thus, there are both conceptual and methodological problems in trying to estimate long-term protection based on data from short-term clinical studies. We discuss the utility of predicting the duration of protection based on extrapolating observed antibody data. Several modeling strategies that have appeared in the clinical and statistical literature are reviewed. Two alternative mixed model strategies are considered and three methods of constructing confidence intervals for the mean duration of protection are proposed. Finally, a sample data set is used to illustrate and compare the various methods.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 189

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G, Ryan J, Provost P, Nalin D. A controlled trial of a Formalin-inactivated hepatitis A vaccine in healthy children. New Engl J Med. 1992;327:453–457.

  2. 2.

    Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol. 1994;44:446–451.

  3. 3.

    Wiens B, Bohidar N, Pigeon J, Egan J, Hurni W, Brown L, Kuter B, Nalin D. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA. J Med Viol. 1996;49:235–241.

  4. 4.

    Wiedemann G, Kundt M, Ambrosch F, Safary A, D’ Hondt E, Delem A. Inactivated hepatitis A vaccine: Long-term antibody persistence. Vaccine. 1997;10(6/7):612–615.

  5. 5.

    Totos G, Gizaris V, Papaevangelou G. Hepatitis A vaccine: Persistence of antibodies 5 years after the first injection. Vaccine. 1997;15(11):1252–1253.

  6. 6.

    Bovier P, Farinelli T, Loutan L, Herzog C, Glueck R. Long-term immunogenicity following immunization with a virosome hepatitis A vaccine. Presented at the Fifth International Conference on Travel Medicine, Geneva, Switzerland, 1997; Abstract 129, 136.

  7. 7.

    Coursaget P, Yvonnet B, Gilks W, Wang C, Day N, Chiron J, Diop-Mar I. Scheduling of revaccination against hepatitis B virus. Lancet. 1991;337:1180–1183.

  8. 8.

    Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine. 1995;13(6):443–447.

  9. 9.

    Schofield T, Lei C. Modelling antibody persistence. Presented at the Eleventh Annual Midwest Biophar-maceutical Workshop, Muncie, IN, May 26, 1988.

  10. 10.

    Miller WJ, Clark W, Hurni W, Kuter B, Schofield T, Nalin D. Sensitive assays for hepatitis A antibodies. J Med Virol 1993;41:201–204.

  11. 11.

    Harville DA. Maximum likelihood approaches to variance component estimation and to related problems. J Am Stat Assoc. 1977;72:320–338.

  12. 12.

    Fieller WC. The biological standardisation of insulin. J Roy Stat Society, Suppl. 1940;7:1–64.

  13. 13.

    Fieller WC. Some problems in interval estimation. J Roy Stat Society, B. 1954;16:175–185.

  14. 14.

    Efron B. Bootstrap methods: Another look at the jackknife. Ann Stat. 1979;7:1–26.

Download references

Author information

Correspondence to Dr. Joseph G. Pigeon PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pigeon, J.G., Bohidar, N.R., Zhang, Z. et al. Statistical Models for Predicting the Duration of Vaccine-Induced Protection. Ther Innov Regul Sci 33, 811–819 (1999) doi:10.1177/009286159903300322

Download citation

Key Words

  • Extrapolation
  • Bootstrap
  • Mixed models
  • Piecewise linear models
  • Fieller’s theorem